Tag Archives: cost-effectiveness

Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model

Posted on 22/01/2024 by

by David J. Price, Narimane Nekkab, Wuelton M. Monteiro, Daniel A. M. Villela, Julie A. Simpson, Marcus V. G. Lacerda, Michael T. White, Angela Devine Background Malaria transmission modelling has demonstrated the potential impact of semiquantitative glucose-6-phosphate dehydrogenase (G6PD) testing … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , | Comments Off on Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model

Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022

Posted on 22/01/2024 by

by Radhika Gharpure, Anna N. Chard, Maria Cabrera Escobar, Weigong Zhou, Molly M. Valleau, Tat S. Yau, Joseph S. Bresee, Eduardo Azziz-Baumgartner, Sarah W. Pallas, Kathryn E. Lafond Background Historically, lack of data on cost-effectiveness of influenza vaccination has been … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , | Comments Off on Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022